Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Evaluate safety, tolerability, and pharmacokinetics of single doses of the investigational
AAB-001 Vaccine in Japanese patients with Alzheimer's disease.